HIGHLIGHTS
- who: Andrei Kachmazov from the National Cheng Kung University Hospital, Taiwan have published the research work: Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review, in the Journal: (JOURNAL)
- what: This clinical case highlights the importance of NGS testing for PDAC patients.
SUMMARY
Chemotherapy regimens continue to dominate the treatment paradigm for PDAC patients despite the distinctive chemo-resistance of this disease. After a longtime struggle to find targets of interest and novel drugs beyond chemotherapy the poly(adenosine_diphosphate-ribose) polymerase . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.